# Urinary incontinence Market > 尿失禁市场研究报告：按类型（压力性尿失禁、急迫性尿失禁、溢出性尿失禁、功能性尿失禁、混合性尿失禁）、按产品（吸收产品、外科产品、药物、神经调节设备、导尿管）、按最终用户（医院、护理院、居家护理、门诊手术中心）、按性别（女性、男性）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 增长前景与行业预测2025至2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 6.22% - **2024:** $ 12.81 Billion - **2025:** $ 13.61 Billion - **2035:** $ 24.88 Billion - **Key Players:** Essity (SE), Kimberly-Clark (US), Procter & Gamble (US), Coloplast (DK), B. Braun (DE), Medtronic (US), Hollister (US), SCA (SE), Attends (US). These companies play a vital role in shaping the urinary incontinence devices market and strengthening their positions within the urinary incontinence device market globally. **Report ID:** MRFR/HC/0591-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** August 11, 2026 **URL:** https://www.marketresearchfuture.com/reports/urinary-incontinence-market-1097 --- ## Market Summary According to Market Research Future analysis, the Urinary Incontinence Market Size was valued at USD 12.81 Billion in 2024 & the market is projected to grow from USD 13.61 Billion in 2025 to USD 24.88 Billion by 2035, registering a CAGR of 6.22% during the forecast period 2025–2035. North America led the market with over 53.40% share, generating around USD 6.84 billion in revenue. Rising aging population and increasing prevalence of chronic conditions are key growth drivers for the urinary incontinence market, as demand for effective management solutions grows, supported by improved awareness, early diagnosis, and expanding access to advanced treatment options globally.   WHO estimates the global population aged 60+ will reach 2.1 billion by 2050, while IHME reports urological disorders contributing to rising disease burden; CDC highlights over 50% of older adults experience bladder control issues, collectively driving strong demand for incontinence management products worldwide. ## Market Drivers ### Market Growth Projections 全球尿失禁市场预计在未来几年将经历强劲增长。到2024年，市场预计将达到32.7亿美元，预计到2035年进一步增长至50亿美元。这一轨迹表明，从2025年到2035年的年均增长率为3.94%。    这样的预测突显了对尿失禁解决方案日益增长的需求，推动因素包括技术进步、人口变化和意识提高。市场的扩展反映了有效管理策略的迫切需求，以应对生活中面临尿失禁挑战的个人。 ### Growing Geriatric Population 全球老年人口的增加是影响全球尿失禁市场的重要因素。随着年龄的增长，因生理变化和合并症而经历尿失禁的可能性增加。    根据人口预测，65岁及以上的人口预计到2050年将翻倍，为尿失禁解决方案创造更大的市场。这一人口变化可能会推动对各种产品的需求，包括[吸收垫](https://www.marketresearchfuture.com/reports/absorbent-pads-market-29198)、药物和外科干预。因此，随着这一老龄化人群需求的日益明显，市场有望实现显著增长。 ### Increased Awareness and Education 对尿失禁的意识和教育的提高是全球尿失禁市场的重要驱动因素。公共卫生运动和教育倡议正在帮助消除对该病症的污名，鼓励个人寻求尿失禁治疗。这种观念的转变至关重要，因为许多人因尴尬而默默忍受。    随着意识的提高，更多的人可能会咨询医疗专业人士，从而导致对产品和服务的需求增加。预计这一趋势将有助于从2025年到2035年的年均增长率达到3.94%，因为越来越多的人认识到解决尿失禁的重要性。 ### Rising Prevalence of Urinary Incontinence 尿失禁在各个群体中的普遍性增加是全球尿失禁市场的主要驱动因素。老龄化人口、肥胖和慢性病等因素促成了这一上升。例如，预计到2024年，市场将达到32.7亿美元，反映出对有效管理解决方案日益增长的需求。世界卫生组织指出，尿失禁影响了相当一部分老年人，患病率在15%到30%之间。这一趋势突显了针对受影响个体需求的创新产品和服务的紧迫性。    综合护理包括盆底肌肉训练、膀胱训练、生活方式调整、皮肤护理和情感支持。通过适当的治疗和护理，尿失禁患者可以显著改善他们的生活质量和日常信心。 ### Regulatory Support and Reimbursement Policies 监管支持和有利的报销政策是全球尿失禁市场的重要驱动因素。各国政府和卫生组织越来越认识到有效管理尿失禁的必要性，从而建立了支持性框架。    例如，许多国家正在实施报销政策，涵盖尿失禁治疗和产品的费用。这种支持不仅减轻了患者的经济负担，还鼓励制造商进行创新和扩展产品。因此，市场可能会在这些有利条件的推动下实现持续增长。 ### Advancements in Urinary incontinence Treatment Technologies 尿失禁治疗选项的技术进步正在推动全球尿失禁市场的发展。微创手术技术、神经调节疗法和先进的吸收产品等创新正在改善患者的治疗效果。    例如，新设备和手术方法的引入提高了疗效并缩短了恢复时间。因此，预计市场将在2035年之前增长至50亿美元，受到这些进步的推动。此外，持续的研究和开发努力可能会产生更有效的解决方案，从而扩大市场并改善患者的生活质量。    尿失禁药物主要用于治疗膀胱过度活跃和急迫性尿失禁。这些药物包括[抗胆碱药物](https://www.marketresearchfuture.com/reports/anticholinergic-drugs-market-7895)和β-3肾上腺素能激动剂，有助于放松膀胱肌肉、减少突发的尿意并改善膀胱控制。在某些情况下，可能还会推荐激素治疗或肉毒毒素注射。    尿失禁设备在症状管理中发挥着重要作用。这些设备包括尿道插入物、阴道托、外部导尿管、吸收垫和先进的[神经调节设备](https://www.marketresearchfuture.com/reports/neuromodulation-devices-market-1337)，帮助调节膀胱神经信号。这些设备提供了非手术选项，以提高舒适度和独立性。 ## Future Outlook 尿失禁市场规模预计到2035年将达到248.8亿美元，年均增长率为6.22%，受到意识提升、技术进步和老龄化人口的推动。 到2035年，市场预计将实现显著增长，受到创新和不断变化的消费者需求的推动。 ## Segment Insights ### 按产品类型：一次性产品（最大）与可重复使用产品（增长最快） 在尿失禁市场中，一次性产品占据了58%的最大市场份额，得益于其广泛的采用和消费者的便利性。该类别包括垫子和尿布等物品，满足了市场中相当大的一部分，主要是由于对优先考虑卫生的单次使用选项的偏好。相反，可重复使用产品已成为增长最快的细分市场。消费者越来越倾向于环保可持续的选择，导致可洗产品的受欢迎程度上升，这些产品在长期使用中提供了成本节省和更高的舒适度。随着消费者偏好的变化，该细分市场的增长趋势正在发生转变。一次性产品细分市场仍然强劲，受到老龄化人口和生活方式变化等因素的推动，这些因素需要便捷的解决方案。与此同时，由于环境意识的提高和对可持续医疗解决方案的推动，可重复使用产品细分市场正在获得动力。这一双重趋势正在重塑市场格局，产品设计和材料的创新进一步推动了可重复使用类别的增长。 一次性产品（主导）与药物（新兴） 在市场中，一次性产品仍然是消费者的主导选择，因其实用性和有效性而广受认可。该细分市场包括一系列选项，如吸收垫和成人尿布，因其易于使用和卫生特性而受到青睐。另一方面，药物代表了一个新兴细分市场，随着新治疗和配方的开发，正在获得关注，以应对失禁挑战。虽然一次性产品提供了快速直接的解决方案，但药物则满足了寻求补救方法的消费者，表明管理尿失禁的方式正在向更全面的方向转变。随着临床进展的持续，药物细分市场有望在尿失禁管理的不断演变中发挥重要作用。 ### 按严重程度：中度（最大）与重度（增长最快） 在尿失禁市场中，严重程度的分布显示，中度类别占据了最大的市场份额，达46%。该细分市场占据了总市场的相当大一部分，受到老年人口中更高的患病率和对治疗选择的认识增加的推动。与此同时，重度类别虽然相对较小，但随着医疗提供者开发出更具创新性和有效性的治疗方案，正在经历快速增长。尿失禁严重程度的增长趋势受到多种因素的影响，包括人口结构的变化，全球老龄化人口导致中度到重度病症的发生率增加。此外，社会对尿失禁的认识和去污名化的增加，鼓励患者更早寻求医疗帮助，推动重度类别成为增长最快的细分市场，因为更全面的解决方案变得可用。 中度（主导）与重度（新兴） 在市场中，中度严重程度代表了主导类别，其特征是患者经历频繁的漏尿，需要生活方式调整，但通常不需要持续的医疗干预。由于生活中有较多中度症状的个体，这一细分市场占据了关键位置，鼓励产品开发旨在提高生活质量，而无需侵入性治疗。相反，重度细分市场正在成为医疗创新的优先事项，企业专注于提供更积极的管理解决方案的先进疗法和设备，以帮助遭受严重症状的患者。该细分市场的增长反映了对针对性干预和改善患者结果的日益需求。 ### 按年龄组：成年人（最大）与老年人（增长最快） 年龄组的分布显示，成年人在尿失禁市场中占据了49%的最大份额，受到生活方式因素和导致失禁的疾病日益普遍的显著影响。儿童和老年人口虽然份额较小，但仍然代表了需要量身定制产品的关键细分市场。成人群体至关重要，得益于其更广泛的信息和医疗资源的获取，推动了对有效失禁解决方案的需求。 主导：成年人与新兴：老年人 成年人细分市场仍然是市场中的主导力量，因其与老龄化、肥胖和分娩引起的压力性失禁相关的显著患病率。另一方面，老年人细分市场被认定为增长最快的细分市场，受到全球老龄化人口和对该病症认识的增加的推动。随着医疗创新的不断发展，越来越强调专门为老年人设计的产品，以满足他们独特的需求和敏感性。这一不断演变的格局突显了两个细分市场在市场动态中的关键角色，各自塑造着尿失禁解决方案的未来。 ### 按性别：女性（最大）与男性（增长最快） 在尿失禁市场中，性别细分显示出明显的分布动态。女性目前占据了57%的最大份额，这与生物学倾向和怀孕、分娩及更年期等生活阶段相关。该人群显著影响了市场中的产品开发和针对性治疗选项，建立了强大的品牌忠诚度和对满足其特定需求的创新解决方案的持续需求。相反，男性细分市场正在迅速崛起，反映出对尿失禁问题的认识和诊断的增加。老龄化人口、男性健康意识的提高以及治疗选择的进步等因素，导致市场份额明显上升。随着社会态度的转变，男性在寻求治疗方面变得更加开放，表明未来几年有强劲的增长潜力。 男性（新兴）与女性（主导） 女性群体仍然是市场中的主导力量，通常是针对性广告和医疗保健倡议的重点。该细分市场受益于对其特定病症的广泛研究，导致适合不同严重程度的多种专业产品的出现。相比之下，男性细分市场正在崛起，受到对尿健康问题的认识提高和污名化减少的推动。为男性量身定制的创新产品和治疗方案开始进入市场，满足对便捷和有效解决方案的需求。这一转变使男性在目标人群中变得越来越重要，使他们能够利用为女性所做的进步，同时在不断演变的市场中开辟出独特的空间。 ### 按分销渠道：药店（最大）与在线（增长最快） 分销渠道在为消费者提供产品方面发挥着关键作用。目前，药店在尿失禁市场中占据主导地位，占52%的市场份额，得益于其广泛的存在和提供个性化咨询的能力。它们仍然是许多患者在购买失禁产品之前寻求药剂师建议的首选。相反，在线分销渠道正在迅速获得关注，吸引寻求便利和隐私的科技敏感消费者。 药店（主导）与在线（新兴） 药店在市场中占据主导地位，提供包括垫子、护垫和导尿管在内的广泛产品。它们的广泛网络使患者能够轻松获取，并通过面对面的互动建立客户信任。此外，药店通常与医疗提供者合作，以确保正确的产品推荐。相反，在线渠道作为一种受欢迎的替代方案正在崛起，受到电子商务增长趋势和对隐私需求的推动。在线平台提供多样化的失禁产品选择，并提供家庭送货的便利，尤其吸引年轻人群。因此，在线销售正在加速增长，使其在分销格局中成为强有力的竞争者。 ## Regional Market Share Analysis ### North America : Market Leader in Innovation North America leads in the Urinary Incontinence Market size, accounting for over 53.40% of the global revenue in 2024. The United States remains a major contributor to the urinary incontinence device market, supported by advanced healthcare systems and product innovation. The region benefits from advanced healthcare infrastructure and significant investments in R&D, leading to innovative product offerings. CDC reports over 25 million Americans experience urinary incontinence, while WHO highlights rising aging population trends; PAHO supports healthcare initiatives across 35+ countries, collectively driving strong adoption of advanced incontinence products and treatment solutions in North America. Regulatory support for medical devices and healthcare solutions further fuels market growth, making it a key player in the global landscape. The United States is the leading country in this market, with major players like Kimberly-Clark and Procter & Gamble dominating the landscape. The competitive environment is characterized by continuous product innovation and strategic partnerships among key players. The presence of established companies ensures a robust supply chain and distribution network, enhancing market accessibility and consumer reach. ### Europe : Emerging Market with Growth Potential Europe Urinary Incontinence Market size was valued at USD 3.84 billion in 2024, making it the second-largest regional market with a 30% share. Innovation in regulatory frameworks and reimbursement policies supports sustainable expansion in both drug and device segments. Regulatory frameworks in the EU promote the development and distribution of innovative healthcare products, which is crucial for market expansion. The region is witnessing a shift towards more personalized and effective incontinence solutions, supported by favorable reimbursement policies. WHO reports 1 in 5 Europeans aged 65+, increasing prevalence of incontinence-related conditions; ECDC supports healthcare system expansion across EU/EEA countries, while UNFPA highlights aging population trends, collectively boosting demand for incontinence management solutions across Europe. Leading countries in this market include Germany, France, and the UK, where companies like Essity and Coloplast are making significant strides. The competitive landscape is marked by a mix of established brands and emerging players, all vying for market share. The presence of key players ensures a diverse range of products, catering to various consumer needs and preferences. ### Asia-Pacific : Rapidly Growing Market Segment The Asia-Pacific urinary incontinence market, valued at 1.92, is experiencing rapid growth due to rising awareness about incontinence issues and improved healthcare access. The Asia-Pacific market is experiencing rapid growth, driven by demographic shifts and increased adoption of modern therapies. This expansion is strengthening the region’s contribution to the global urinary incontinence devices market.  Governments in the region are also focusing on enhancing healthcare infrastructure, which supports market growth and product availability. Countries like Japan and Australia are leading the market, with key players such as Medtronic and Hollister actively participating. The competitive landscape is evolving, with both local and international companies striving to meet the growing demand. Innovations in product design and functionality are becoming essential for capturing market share in this dynamic environment. ### Middle East and Africa : Untapped Market Opportunities The Middle East and Africa urinary incontinence market is currently valued at 0.21, indicating significant untapped potential. Factors such as increasing awareness of urinary health and a growing elderly population are beginning to drive demand for incontinence products. However, the market is still in its infancy, with limited product availability and awareness among consumers. Regulatory bodies are starting to recognize the need for better healthcare solutions, which may catalyze future growth. Countries like South Africa and the UAE are at the forefront of this emerging market. The competitive landscape is characterized by a few key players, but there is ample opportunity for new entrants to establish themselves. As awareness increases and healthcare infrastructure improves, the market is expected to grow, attracting both local and international companies looking to capitalize on this opportunity. ## Competitive Benchmarking The Urinary incontinence Market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on patient-centric solutions. Key players such as Essity (SE), Kimberly-Clark (US), and Coloplast (DK) are actively pursuing strategies that emphasize product development and market expansion. For instance, Essity (SE) has been focusing on enhancing its product portfolio through sustainable practices, which aligns with the growing consumer demand for environmentally friendly options.   Meanwhile, Kimberly-Clark (US) has been investing in digital transformation initiatives to improve customer engagement and streamline operations, thereby enhancing its competitive positioning.The market structure appears moderately fragmented, with several players vying for market share. Companies are increasingly localizing manufacturing and optimizing supply chains to respond swiftly to regional demands. This approach not only reduces operational costs but also enhances responsiveness to market fluctuations. The collective influence of these key players suggests a dynamic environment where innovation and operational efficiency are paramount.   In November Coloplast (DK) announced the launch of a new line of absorbent products designed specifically for the elderly population, which is projected to grow significantly in the coming years. This strategic move is likely to strengthen Coloplast's market presence and cater to a demographic that requires specialized solutions, thereby enhancing its competitive edge. The introduction of these products reflects a broader trend towards personalization in healthcare, which is becoming increasingly important in the urinary incontinence sector.   In October Kimberly-Clark (US) unveiled a partnership with a leading telehealth provider to integrate digital health solutions into its product offerings. This collaboration aims to provide consumers with better access to information and support regarding urinary incontinence management. By leveraging technology, Kimberly-Clark is positioning itself as a forward-thinking leader in the market, potentially reshaping how consumers interact with urinary incontinence products and services.   In September Essity (SE) expanded its operations in Asia by establishing a new manufacturing facility in Vietnam. This strategic expansion is indicative of the company's commitment to tapping into emerging markets, where demand for urinary incontinence products is on the rise. By localizing production, Essity not only reduces shipping costs but also enhances its ability to meet local consumer needs more effectively.   As of December the competitive trends in the Urinary incontinence Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. The shift from price-based competition to a focus on technological advancements and supply chain reliability is evident. Moving forward, competitive differentiation will likely hinge on the ability to innovate and adapt to changing consumer preferences, with a strong emphasis on sustainability and personalized solutions. ## Recent News & Developments Recent developments in stress incontinence therapies and artificial urinary sphincter technologies are further shaping the stress urinary incontinence market and contributing to expansion in the female urinary incontinence sling market. These advancements are expected to positively impact the overall market in the coming years. An important advancement for a non-surgical, automated artificial urinary sphincter was marked on February 20th, 2025, when UroMems announced successful mid-term results from its first clinical feasibility study of the UroActive smart implant for treating stress urinary incontinence (SUI) in women. The results showed a reduction from 125 g to 4 g in a one-hour pad test. Medscape announced on April 28, 2025, that UroMems's UroActive device, which offers patients a less invasive and more convenient incontinence therapy, may be implanted robotically and managed remotely. Under the direction of urogynecologists at Stanford, NYU Langone, and Jefferson Health, Watkins-Conti Products concluded a multicenter clinical study of its Yōni.Fit vaginal insert for stress urine incontinence on April 20, 2023, in order to get ready to submit a 510(k) to the FDA. The U.S. CDC-funded National Association for Continence (NAFC) and Phreesia, Health.Equity, began a three-year awareness campaign on May 5, 2025.results, and Christina Escobar of NYU to de-stigmatize female incontinence and encourage early intervention. The PeriCoach, a home-based Kegel training tool with an app that improves pelvic-floor strengthening and patient compliance, was unveiled by Analytica Ltd. in October 2023. These achievements mark important breakthroughs in the treatment of urine incontinence worldwide on the clinical, technical, and educational fronts. ## Report Scope | MARKET SIZE 2024 | 12.81(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 13.61(USD Billion) | | MARKET SIZE 2035 | 24.88(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.22% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Essity (SE), Kimberly-Clark (US), Procter & Gamble (US), Coloplast (DK), B. Braun (DE), Medtronic (IE), Hollister (US), SCA (SE), Attends (US) | | Segments Covered | Product Type, Severity Level, End User, Gender | | Key Market Opportunities | Advancements in wearable technology enhance management solutions in the market. | | Key Market Dynamics | Rising demand for innovative urinary incontinence products drives competitive forces and technological advancements in the market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the current valuation of the Urinary Incontinence Market as of 2024?** A: The Urinary Incontinence Market was valued at 12.81 USD Billion in 2024. **Q: What is the projected market size for the Urinary Incontinence Market by 2035?** A: The market is projected to reach 24.88 USD Billion by 2035. **Q: What is the expected CAGR for the market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during 2025 - 2035 is 6.22%. **Q: Which product type segment had the highest valuation in 2024?** A: In 2024, the Disposable Products segment had the highest valuation at 3.84 USD Billion. **Q: How does the market valuation for Reusable Products compare to Disposable Products in 2024?** A: In 2024, Reusable Products were valued at 2.56 USD Billion, significantly lower than Disposable Products. **Q: What is the market size for Urinary Incontinence products among the elderly in 2024?** A: The market size for Urinary Incontinence products among the elderly was 6.31 USD Billion in 2024. **Q: Which gender segment accounted for the largest market share in 2024?** A: In 2024, the Female segment accounted for the largest market share at 7.68 USD Billion. **Q: What distribution channel generated the highest revenue in 2024?** A: The Pharmacy distribution channel generated the highest revenue in 2024, valued at 5.12 USD Billion. **Q: What is the projected market size for Surgical Devices by 2035?** A: The market size for Surgical Devices is projected to reach 4.4 USD Billion by 2035. **Q: Which key players are leading the Urinary Incontinence Market?** A: Key players in the market include Essity, Kimberly-Clark, Procter & Gamble, and Coloplast. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/urinary-incontinence-market-1097*